Neutralizing human anti-IGFR antibody
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Schering Corporation
C C A A A C A A A C C C C A A C
C07K C07K A61P A61P A61P C07K A61P A61P A61K C07K C07K C07K C07K A61P A61P C07K
inventional additional inventional inventional inventional additional inventional inventional additional additional additional additional inventional inventional inventional additional
Jonathan A. Peter Mohan Robert Leonard Judith Diane Yan Denise
Pachter Brams Srinivasan Greenberg Presta Hailey Feingersh Wang Williams